Tumor necrosis factor (TNF) inhibitors led to no ... of TNF inhibitors is required in all patients with rheumatoid arthritis–associated ILD. However, given disease heterogeneity and imprecision ...

Source Reference: McDermott GC, Sparks JA "Tumour necrosis factor inhibitor safety in rheumatoid arthritis-associated interstitial lung disease" Lancet Rheumatol 2025; DOI: 10.1016 ...

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate ... in the management of patients with rheumatoid arthritis-associated ILD [interstitial lung disease]," the researchers wrote.

Rheumatoid factor is felt to be less useful ... infiltrate (such as sicca symptoms, hypothyroidism, interstitial lung disease, splenomegaly, or lymphadenopathy). RA is a clinical diagnosis with ...

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis ... drug-induced liver injury (DILI), opportunistic infections or interstitial lung disease (ILD). Adjudicated ...

Treatment with TNF inhibitors yielded no differences in outcomes vs. other antirheumatic therapies among U.S. veterans with ...

Marking Rheumatoid Arthritis Awareness Day 2025 on February 2, it's essential to shed light on the often-overlooked connection between RA and lung health. Can rheumatoid arthritis cause lung damage?

Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.

Current research has not found an association between rheumatoid arthritis and appendicitis, but some studies found a link between other autoimmune diseases and appendicitis.

Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects the joints, but it can impact other organs and systems in the body, including the skin. For many people with RA ...

Women with an age at first birth (AFB) younger than 26 or older than 35 years have a higher risk for developing rheumatoid ...